RecoverX

What RecoverX does

Evidium, Inc. (operating as Evidium and the company referenced in this dataset under the firmographic name RecoverX) is a privately held US-based healthcare technology company founded in 2021, headquartered in San Francisco, with 11-50 employees. It builds "world models for healthcare" — a computational intelligence architecture that projects patients over a computable map of clinical states, the transitions between those states, and the causal factors driving those transitions. Where general LLMs can discuss medical knowledge, Evidium positions its platform as computing the dynamics of that knowledge, with every insight traced to clinical evidence and real-world events. The platform supports disease progression forecasting, cost-trajectory modeling, and trajectory-based clinical decision support, and is explicitly designed as a substrate on which AI agents can ground their actions in real-world clinical dynamics.

The product surface consists of a core Evidium Platform and four vertical-specific solution modules: Self-Insured Solutions (targeting employer benefits and stop-loss/risk strategy), Health Plans Solutions (targeting payer care and cost modeling, pricing precision, and risk alignment), Hospitals and Health Systems Solutions (targeting trajectory-based patient insight and care coordination), and Research & Therapeutic Strategy Solutions (targeting treatment response modeling, emerging therapy assessment, and real-world evidence generation). The company serves four distinct healthcare buyer segments — self-insured employers, health insurers, provider organizations, and life sciences/research entities.

The business model is enterprise B2B SaaS delivered through a consultative, field-sales motion with no publicly disclosed pricing; the website uses "Get in touch" CTAs across all segments, indicating quote-based contracts likely tiered by organization size and scope. Distribution is direct enterprise sales, with marketing driven primarily through content (blog, resources), mission-based brand positioning, and direct outreach. Capital structure evidence is limited to a single seed funding event recorded in January 2023, and only one named executive (Chief Product Officer David A. Epstein) is disclosed.

Name

RecoverX

Legal name

Evidium, Inc.

Website

https://recoverx.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Evidium is a US-based healthcare technology company that builds proprietary "world models" — computational systems that model patient clinical states and disease progression — sold via enterprise SaaS to self-insured employers, health plans, hospitals, and life sciences researchers.

Ownership category

akta.pro rank

Product category

Healthcare AI / Clinical Decision Intelligence Software

NAICS

Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Commercial Physical & Biological Research (8731), Services-Computer Programming Services (7371)

akta.pro primary industry

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

Keywords

• Healthcare AI platform
• Clinical decision intelligence
• Disease progression forecasting
• Medical knowledge computing
• Healthcare predictive analytics

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Healthcare Intelligence Platform: Enterprise software platform providing computational medical knowledge intelligence to healthcare organizations. The platform serves multiple stakeholder types (self-insured employers, health plans, health systems, research organizations) suggesting a B2B SaaS model with potential tiered pricing based on organization type and usage scope.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

RecoverX (operating as Evidium, Inc.) sells a computational healthcare intelligence platform that projects patients over a computable map of clinical states, transitions between those states, and the causal factors driving them. Built on proprietary "world models for healthcare," the platform combines LLMs for medical knowledge discussion with computational modeling of clinical dynamics, and is delivered through segment-specific solutions for self-insured employers, health plans, hospitals/health systems, and life sciences research organizations.

Product overview

Evidium offers a unified platform architecture centered on its core Evidium Platform, which provides computational world models for healthcare. The platform is complemented by four solution modules targeting specific healthcare segments: Self-Insured Solutions for employer benefits and risk management, Health Plans Solutions for payer cost and care modeling, Hospitals and Health Systems Solutions for trajectory-based patient insight, and Research & Therapeutic Strategy Solutions for drug development and evidence generation. These modules share the underlying computational infrastructure while addressing distinct market needs.

Differentiator

Problem solved

Functional benefit

Products and services

• Evidium Platform Computational healthcare intelligence platform that makes medical knowledge computational by projecting patients over a computable map of clinical states, transitions between states, and causal factors. Enables healthcare experts to understand patient conditions and supports AI agents in grounding their actions in real-world clinical dynamics, with every insight traced to clinical evidence and real-world events.
• Self-Insured Solutions Solution for self-insured employers that delivers earlier forecasting of disease progression and cost trajectories to anticipate severity and financial volatility. Aligns financial planning, stop-loss strategy, and reserve confidence with clinical reality, helping reduce high-cost claims and risk exposure to improve long-term cost stability and employee health.
• Health Plans Solutions Solution for health plans that strengthens margin stability through care and cost modeling across populations. Connects clinical and claims insight to improve pricing precision, risk alignment, and performance across lines of business, and drives better member health by aligning clinical insight with timely, targeted action.
• Hospitals and Health Systems Solutions Solution for hospitals and health systems that advances quality and care delivery through trajectory-based patient insight. Enables earlier intervention, stronger guideline adherence, and coordinated care across complex longitudinal treatment journeys.
• Research & Therapeutic Strategy Solutions Solution for life sciences research and therapeutic strategy that accelerates scientific understanding by modeling disease progression and therapeutic impact. Supports computational analysis of treatment response, informs assessment of emerging therapies and novel care strategies, and expands real-world evidence generation across evolving standards of care.

Quantifiable outcome

• Earlier identification of disease progression and cost trajectories
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Tempus Labs: Tempus applies AI to multi-modal clinical and molecular data to support precision medicine and disease progression insights. Most directly comparable to Evidium's Research & Therapeutic Strategy and Health Systems modules, with overlapping RWE and clinical intelligence capabilities.
• Komodo Health: Komodo builds a healthcare intelligence map from de-identified patient-level data to track disease trajectories and outcomes. Closest direct peer to Evidium's world-models approach to projecting patients across clinical states for payers, providers, and pharma.
• Flatiron Health: Flatiron aggregates oncology EHR data to generate real-world evidence and support clinical decision-making. Comparable to Evidium's evidence-grounded clinical state modeling and pharma RWE offerings.
• Clarify Health: Clarify provides value-based care analytics combining claims and clinical data for payers and providers. Directly comparable to Evidium's Health Plans and Self-Insured employer cost-and-care modeling modules.

Emerging players

• Atropos Health: Atropos generates real-world evidence from electronic health record data to answer clinical questions on demand. Comparable to Evidium's Research & Therapeutic Strategy use cases, with narrower scope and smaller scale.
• H1 (H1.co): H1 provides healthcare data intelligence connecting life sciences companies with clinicians, sites, and real-world data. Overlaps with Evidium's pharma RWE and provider intelligence offerings, though focused more on HCP-level data.
• Owkin: Owkin applies AI/federated learning to patient data for drug discovery and clinical research. Comparable in life-sciences AI orientation and use of clinical evidence, though anchored in academic medical centers rather than US payers.

Others

• Datavant: Datavant provides the data connectivity layer that links de-identified health records and claims across organizations. Adjacent to Evidium — enabling infrastructure that supports RWE workflows — rather than a direct analytics competitor.

Broad incumbents

• Health Catalyst: Health Catalyst is an established healthcare data and analytics platform serving health systems and payers with population health and cost-of-care insights. Comparable in targeting and workflow integration, but broader and more general-purpose than Evidium's computational world models.
• Arcadia: Arcadia delivers population health management analytics to health systems, payers, and employers on top of aggregated clinical and claims data. Overlaps with Evidium's payer/employer cost-trajectory forecasting, though as a broader analytics suite rather than a disease-progression compute engine.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/teamrecoverx

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RecoverX